Pleural Effusions from Patients with Mesothelioma Induce Recruitment of Monocytes and Their Differentiation into M2 Macrophages-Reference-Cited by-同舟云学术

Pleural Effusions from Patients with Mesothelioma Induce Recruitment of Monocytes and Their Differentiation into M2 Macrophages

Published:2016-10 Issue:10 Volume:11 Page:1765-1773
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Chéné Anne-Laure,d’Almeida Sènan,Blondy Thibaut,Tabiasco Julie,Deshayes Sophie,Fonteneau Jean-François,Cellerin Laurent,Delneste Yves,Grégoire Marc,Blanquart Christophe

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference28 articles.

1. New roads open up for implementing immunotherapy in mesothelioma;Cornelissen;Clin Dev Immunol,2012

2. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm;Biswas;Nat Immunol,2010

3. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes;Mantovani;Trends Immunol,2002

4. Alternative activation of macrophages: an immunologic functional perspective;Martinez;Annu Rev Immunol,2009

5. Anti-tumour strategies aiming to target tumour-associated macrophages;Tang;Immunology,2013

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hesperidin PLGA nanoparticles potentiate the efficacy of aPD-1 in treating triple negative breast cancer by regulating CCL2 and ADPN expression in cancer-associated adipocytes;International Immunopharmacology;2024-10

2. Interplay between oncolytic measles virus, macrophages and cancer cells induces a proinflammatory tumor microenvironment;OncoImmunology;2024-07-10

3. Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream;Frontiers in Immunology;2024-01-08

4. The Immunological Landscape of M1 and M2 Macrophages and Their Spatial Distribution in Patients with Malignant Pleural Mesothelioma;Cancers;2023-10-24

5. PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesothelioma;Journal for ImmunoTherapy of Cancer;2023-10